Early p53 mutations in nondysplastic Barrett's tissue detected by the restriction site mutation (RSM) methodology

British Journal of Cancer

Volumn 88, Issue 8, 2003, Pages 1271-1276

  Jenkins, G J S ^a   Doak, S H ^b   Griffiths, A P ^c   Tofazzal, N ^c   Shah, V ^d   Baxter, J N ^c   Parry, J M ^b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c MORRISTON HOSPITAL   (United Kingdom)

^d SINGLETON HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Biomarker; Mutation; p53 gene

Indexed keywords

PROTEIN P53; TUMOR MARKER;

ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; DYSPLASIA; GENE AMPLIFICATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; METAPLASIA; PRECANCER; PRIORITY JOURNAL; RESTRICTION SITE; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE;

BARRETT ESOPHAGUS; BASE SEQUENCE; BIOPSY; GENES, P53; HUMANS; PRECANCEROUS CONDITIONS; RESTRICTION MAPPING;

EID: 0037809358     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600891     Document Type: Article

References (32)

1. Ambs S, Bennett WP, Merriam WG, Ogunfusika MO, Oser SM, Harrington AM, Shields PG, Felley-Bosco E, PerwezHussain S, Harris CC (1999) Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J Natl Cancer Inst 91: 86 - 89
2. Audrezet MP, Robaszkiewicz M, Mercier B, Nousbaum JB, Hardy E, Bail JP, Volant A, Lozach P, Gouerou H, Ferec C (1996) Molecular analysis of the TP53 gene in Barrett's adenocarcinoma. Hum Mutat 7: 109 - 113
3. Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C (2001) p53 gene mutation and protein accumulation during neoplastic progression in Barrett's oesophagus. Mod Pathol 14: 397 - 403
4. Bouffler SD, Kemp C, Balmain A, Cox R (1995) Spontaneous and ionizing radiation induced chromosomal abnormalities in p53 deficient mice. Cancer Res 55: 3883 - 3889
5. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA (1991) p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 51: 4495 - 4499
6. Cameron AJ, Ott BJ, Payne, WS (1985) The incidence of adenocarcinoma in columnar lined (Barrett's) oesophagus. N Eng J Med 313: 857 - 859
7. Campomenosi P, Conio M, Bogliola M, Urbani S, Assereto P, Aprile A, Monti P, Aste H, Lapertosa G, Inga A, Abbondandola A, Fronza G (1996) p53 is frequently mutated in Barrett's metaplasia of the intestinal type. Cancer Epidemiol Biomarkers Prevention 5: 559 - 565
8. Cerutti PA, Trump BA (1991) Inflammation and oxidative stress in carcinogenesis. Cancer Cells 3: 1 - 7
9. Chen XX, Yang CS (2001) Esophageal adenocarcinoma: a review and perspectives on mechanism of carcinogenesis and chemoprevention. Carcinogenesis 22: 1119 - 1129
10. Dreher D, Junod AF (1996) Role of oxygen free radicals in cancer development. Eur J Cancer 32A: 30 - 38
11. Fitzgerald RC, Triadafilopoulos G (1998) Recent developments in the molecular characterisation of Barrett's esophagus. Dig Dis Sci 16: 63 - 80
12. Fukasawa K, Choi T, Kuriyama R, Rulong S, VandeWoude GF (1996) Abnormal centrosome amplification in the absence of p53. Science 271: 1744 - 1747
13. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Russell SHE (1995) Base transitions at CpG dinucleotides in the p53 gene are common in esophogeal adenocarcinoma. Cancer Res 55: 3406 - 3411
14. Gleeson CM, Sloan JM, McManus DT, Maxwell P, Arthur K, McGuigan JA, Ritchie AJ, Russell SHE (1998) Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia. Br J Cancer 77: 277 - 286
15. Hamelin R, Flejou J-F, Muzeau F, Potet F, Larent Puig P, Fekete F, Thomas G (1994) TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology 107: 1012 - 1018
16. Hainaut P, Hollstein M (2000) p53 and human cancer the first ten thousand mutations. Adv Cancer Res 77: 81 - 137
17. Havre PA, Yuan J, Hedrick L, Cho KR, Glazer PM (1995) p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res 55: 4420 - 4424
18. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, Kerr D, Young LS (1999) Molecular evolution of the metaplasia - dysplasia - adenocarcinoma sequence in the esophagus. Am J Pathol 154: 965 - 973
19. Jenkins GJS, Doak SH, Parry JM, Griffiths AP, Baxter JN (2002) Barrett's metaplasia, the genetic pathways involved in its progression to adenocarcinoma. Br J Surg 89: 824 - 837
20. Jenkins GJS, Williams GL, Beynon J, Ye Z, Baxter JN, Parry JM (2001a) Restriction enzymes: a molecular tool for analysing the genetic alterations in cancer progression. Br J Surg 89: 8 - 20
21. Jenkins GJS, Suzen HS, Sueiro, RA Parry JM (1999) The restriction site mutation (RSM) assay. A review of the methodology development and the current status of the technique. Mutagenesis 14: 439 - 448
22. Jenkins GJS, Morgan C, Parry EM, Baxter JN, Parry JM (2001b) The detection of mutations induced in vitro in the human p53 gene by hydrogen peroxide with the restriction site mutation (RSM) assay. Mutat Res 498: 135 - 144
23. Krishnadath KK, Wang KK, Taniguchi K, Sebo TJ, Buttar NS, Anderson MA, Lutzke LS, Liu W (2000) Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 119: 624 - 630
24. Minamoto T, Ronai Z (2001) Gene mutation as a target for early detection in cancer diagnosis. Crit Rev Onco/Hematol 40: 195 - 213
25. Neshat K, Sanchez CA, Galipeau PC, Blount PL, Levine DS, Joslyn G, Reid BJ (1994) p53 mutations in Barrett's adenocarcinoma and highgrade dysplasia. Gastroenterology 106: 1589 - 1595
26. Prevo LJ, Sanchez CA, Galipeau PC, Reid BJ (1999) p53 mutant clones and field effects in Barrett's esophagus. Cancer Res 59: 4784 - 4787
27. Pfeiffer GP (2000) p53 mutational spectra and the role of methylated CpG sequences. Mutat Res 450: 155 - 166
28. Reid BJ (2001) p53 and neoplastic progression in Barrett's oesophagus. Am J Gastroenterol 96: 1321 - 1323
29. Schneider PM, Casson AG, Levin B, Garewal HS, Hoelscher AH, Becker K, Dittler HJ, Cleary KR, Troster M, Siewert JR, Roth JA (1996) Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of 98 cases. J Thorac Cardiovasc Surg 111: 323 - 333
30. Schneider PM, Stoeltzing O, Roth JA, Hoelscher AH, Wegerer S, Mizumoto S, Becker K, Dittler HJ, Fink U, Siewert JR (2000) p53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus. Clin Cancer Res 6: 3153 - 3158
31. Sjoqvist U, Ost A, Lofberg R (1999) Increased expression of proliferative Ki67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis. Int J Colorectal Dis 14: 107 - 113
32. Watson A (2000) Barrett's oesophagus: 50 years on. Br J Surg 87: 529 - 531